Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Device Global Registry for the IlluminOss Bone Stabilization System
NCT05206981 · View on ClinicalTrials.gov ↗
Study Summary
This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
Conditions Studied
Interventions
- DEVICE IlluminOss Device
Study Locations (16)
Other
- St Vinzenz Hospital — Cologne
- Johannes Wesling Hospital Minden — Minden
- Petrus Hospital — Wuppertal
Florida
- University of Miami Hospital — Miami
- Weston Outpatient Surgical Center — Weston
North Carolina
- Mission Hospital — Asheville
- Wake Forest Baptist Health — Winston-Salem
Pennsylvania
- Temple University Hospital — Philadelphia
- University of Pittsburgh Medical Center — Pittsburgh
Alabama
- Gulf Orthopedics — Mobile
California
- Cedars-Sinai Medical Center — Los Angeles
Colorado
- Presbyterian St Luke's Medical Ctr — Denver
Indiana
- Parkview Health — Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05206981
The ClinicalTrials.gov registry entry for NCT05206981 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IlluminOss Medical, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Pathological Fracture appearing as the primary indexed condition, and to 1 intervention — of which IlluminOss Device is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05206981 reports 16 study locations spanning 11 distinct geographic areas — top geographies include Other, Florida, North Carolina. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05206981 about?
NCT05206981 is a clinical study titled "Device Global Registry for the IlluminOss Bone Stabilization System". This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
What is the current status of trial NCT05206981?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-06-11. Estimated completion is 2026-12.
What conditions does trial NCT05206981 study?
This clinical trial studies the following conditions: Pathological Fracture, Traumatic Fracture. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05206981?
The interventions under investigation include: IlluminOss Device (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05206981?
This trial is sponsored by IlluminOss Medical, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05206981 being conducted?
This trial has 16 study locations across Alabama, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.